Geron Corp (NASDAQ: GERN) on Tuesday, plunged -7.00% from the previous trading day, before settling in for the closing price of $2.57. Within the past 52 weeks, GERN’s price has moved between $1.64 and $5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 72.04%. The company achieved an average annual earnings per share of 21.15%. With a float of $567.45 million, this company’s outstanding shares have now reached $603.10 million.
Let’s determine the extent of company efficiency that accounts for 141 employees. In terms of profitability, gross margin is 96.53%, operating margin of -705.46%, and the pretax margin is -682.48%.
Geron Corp (GERN) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Geron Corp is 6.13%, while institutional ownership is 75.67%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp (GERN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.15% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Geron Corp (GERN) is currently performing well based on its current performance indicators. A quick ratio of 2.74 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 49.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.32, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.06 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Looking closely at Geron Corp (NASDAQ: GERN), its last 5-days average volume was 13.74 million, which is a jump from its year-to-date volume of 11.98 million. As of the previous 9 days, the stock’s Stochastic %D was 16.69%. Additionally, its Average True Range was 0.15.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 0.66%, which indicates a significant decrease from 2.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.08% in the past 14 days, which was higher than the 41.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.15, while its 200-day Moving Average is $4.01. However, in the short run, Geron Corp’s stock first resistance to watch stands at $2.52. Second resistance stands at $2.65. The third major resistance level sits at $2.72. If the price goes on to break the first support level at $2.32, it is likely to go to the next support level at $2.25. Now, if the price goes above the second support level, the third support stands at $2.12.
Geron Corp (NASDAQ: GERN) Key Stats
Market capitalization of the company is 1.44 billion based on 604,501K outstanding shares. Right now, sales total 240 K and income totals -184,130 K. The company made 28,270 K in profit during its latest quarter, and -26,450 K in sales during its previous quarter.
